← All Authorities
Singapore
Millennium Pharmaceuticals, Inc. v Zyfas Medical Co (Sued as a firm)
[2020] SGHC 28
Key Principle
Statutory Interpretation — Construction of statute — Regulation 24(1)(a)(ii) of the Health Products (Therapeutic Products) Regulations 2016 (S329/2016) – Whether an operative omission under reg 24(1)(a)(ii) requires that the defendant knowingly or intentionally omits to state the existence of relevant patents
Area of Law
Statutory Interpretation
Related Cases
Ask CommonBench about this case
Get a detailed analysis of Millennium Pharmaceuticals, Inc. v Zyfas Medical Co (Sued as a firm) and how it applies to your situation.
Explain Millennium Pharmaceuticals, In...